News About: Pharm. Industry
Hanmi Pharm invests KRW 150 billion into Smart Plant
“Since 2015, Hanmi Pharm has invested about KRW 150 billion into constructing the Paltan Industrial Complex Smart Plant; we are still planning to invest more to equip the plant. Literally, it is the largest facilities...
Who’s leading in entering U.S. market this year?
There is a market that Korean pharmaceutical companies are constantly knocking its door with confidence from their proud R&D results. It’s the U.S.
The U.S. medicine market is evaluated the world’s best medicine mark...
GSK’s antacid and antihistamine ‘Zantac Tab’
The Ministry of Food and Drug Safety(MFDS) imposed an administrative measure of 3-month import suspension from 20 March to 19 June on ‘Zantac 150mg,’ an GlaxoSmithKline’s antacid and antihistamine.
The MFDS said Glax...
Hanmi Pharm’s incrementally modified drug ‘Esmezole’ mentioned in USP
‘Esomezol(generic name: esomeprazole strontium tetrahydrate),’ an incrementally modified drug developed by Hanmi Pharm, will be mentioned in the United States Pharmacopeia.
Pharmacopoeia, a book with legal force, is ...
Korean pharmas signed technology export agreements worth of USD 1.23 billion last year
The amount of earnings Korean pharmaceutical companies contracted by exporting technology last year was reportedly KRW USD 1.23 billion at most.
The Ministry of Health and Welfare(MOHW) researched technology exports ...
Celltrion’s personnel reshuffle in C-level
Celltrion Group will perform a personnel reshuffle to establish a base to expand and accelerate its global biopharmaceutical business.
According to Celltrion Group, Celltrion promoted CO-CEO Woo-Sung Ki and Hyung-Gi ...
Pharmaceutical industry has high potentials for Korea-India cooperation
The pharmaceutical industry has been chosen as a potential industry for Korean small & medium companies to cooperate between Korea and India. An analysis result showed it a rare case where Korea and India might genera...
‘Edarbi’ co-marketed by Takeda Pharmaceuticals & Dong-A ST enters Seoul National University Hospital
‘Edarbi’ jointly sold by Takeda Pharmaceuticals and Dong-A ST has entered Seoul National University Hospital.
At the Drug Committee on the last 2nd, Seoul National University let various drugs, like ‘Edarbi.’ LG Chem...
Korean pharmas getting closer to U.S. market, changing market trend within 4 to 5 years
Pharmaceutical companies dreaming to become a global pharmaceutical company are focusing on creating new drug pipelines. This is because it seems they might be decided to become one by how successful their new drug pi...
SK Chemicals signs exclusive supply agreement of Parkinson’s treatment with Portuguese BIAL
SK Chemicals will supply treatments for Parkinson’s disease patients with motor fluctuation in Korea.
SK Chemicals announced on the 5th that the company has signed a license agreement of exclusive supply of ‘Ongentys...
